Literature DB >> 9109450

Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors.

O P Rekvig1, U Moens, A Sundsfjord, G Bredholt, A Osei, H Haaheim, T Traavik, E Arnesen, H J Haga.   

Abstract

We have previously demonstrated that experimental expression of the polyomavirus transcription factor T-antigen has the potential to induce anti-DNA antibodies in mice. Two sets of independent evidences are presented here that demonstrate a biological relevance for this model. First, we describe results demonstrating that mice inoculated with T-antigen-expressing plasmids produced antibodies, not only to T-antigen and DNA, but also to the DNA-binding eukaryotic transcription factors TATA-binding protein (TBP), and to the cAMP-response-element-binding protein (CREB). Secondly, we investigated whether polyomavirus reactivation occurs in SLE patients, and whether antibodies to T-antigen, DNA, and to TBP and CREB are linked to such events. Both within and among these SLE patients, frequent polyomavirus reactivations were observed that could not be explained by certain rearrangements of the noncoding control regions, nor by corticosteroid treatment. Linked to these events, antibodies to T-antigen, DNA, TBP, and CREB were detected, identical to what we observed in mice. Antibodies recognizing double-stranded DNA were confined to patients with frequent polyomavirus reactivations. The results described here indicate that cognate interaction of B cells recognizing DNA or DNA-associated proteins and T cells recognizing T antigen had taken place as a consequence of complex formation between T ag and DNA in vivo in the context of polyomavirus reactivations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109450      PMCID: PMC508030          DOI: 10.1172/JCI119373

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Survey of urine from transplant recipients for polyomaviruses JC and BK using the polymerase chain reaction.

Authors:  W F Marshall; A Telenti; J Proper; A J Aksamit; T F Smith
Journal:  Mol Cell Probes       Date:  1991-04       Impact factor: 2.365

2.  Residues that mediate DNA binding of autoimmune antibodies.

Authors:  M Z Radic; J Mackle; J Erikson; C Mol; W F Anderson; M Weigert
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

3.  Structural similarity of antibody variable regions from immune and autoimmune anti-DNA antibodies.

Authors:  M R Krishnan; T N Marion
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

4.  Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction.

Authors:  T Flaegstad; A Sundsfjord; R R Arthur; M Pedersen; T Traavik; S Subramani
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

5.  Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients.

Authors:  S Muller; P Richalet; A Laurent-Crawford; S Barakat; Y Rivière; F Porrot; S Chamaret; J P Briand; L Montagnier; A Hovanessian
Journal:  AIDS       Date:  1992-09       Impact factor: 4.177

6.  Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.

Authors:  R B Markowitz; H C Thompson; J F Mueller; J A Cohen; W S Dynan
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

Review 7.  Selection of immunoglobulin variable regions in autoimmunity to DNA.

Authors:  T N Marion; D M Tillman; N T Jou; R J Hill
Journal:  Immunol Rev       Date:  1992-08       Impact factor: 12.988

8.  DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood.

Authors:  D J Bergsagel; M J Finegold; J S Butel; W J Kupsky; R L Garcea
Journal:  N Engl J Med       Date:  1992-04-09       Impact factor: 91.245

9.  Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites.

Authors:  D V Vlahakos; M H Foster; S Adams; M Katz; A A Ucci; K J Barrett; S K Datta; M P Madaio
Journal:  Kidney Int       Date:  1992-06       Impact factor: 10.612

10.  Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice.

Authors:  D M Tillman; N T Jou; R J Hill; T N Marion
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  33 in total

1.  Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells.

Authors:  Manar Kalaaji; Elin Mortensen; Leif Jørgensen; Randi Olsen; Ole Petter Rekvig
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 2.  The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved.

Authors:  Ole Petter Rekvig; Johan Van der Vlag
Journal:  Semin Immunopathol       Date:  2014-04-25       Impact factor: 9.623

3.  The Epstein-Barr virus and systemic lupus erythematosus.

Authors:  J H Vaughan
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

Review 4.  Mechanisms of transcriptional regulation of cellular genes by SV40 large T- and small T-antigens.

Authors:  U Moens; O M Seternes; B Johansen; O P Rekvig
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

Review 5.  Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity.

Authors:  Jolien Suurmond; Betty Diamond
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

Review 6.  The anti-DNA antibody: origin and impact, dogmas and controversies.

Authors:  Ole P Rekvig
Journal:  Nat Rev Rheumatol       Date:  2015-06-02       Impact factor: 20.543

7.  Acquired loss of renal nuclease activity is restricted to DNaseI and is an organ-selective feature in murine lupus nephritis.

Authors:  Natalya Seredkina; Ole P Rekvig
Journal:  Am J Pathol       Date:  2011-06-30       Impact factor: 4.307

8.  Autoimmune-like syndromes during TNF blockade: does infection have a role?

Authors:  Joerg C Prinz
Journal:  Nat Rev Rheumatol       Date:  2011-03-29       Impact factor: 20.543

Review 9.  Self-dsDNA in the pathogenesis of systemic lupus erythematosus.

Authors:  Y Bai; Y Tong; Y Liu; H Hu
Journal:  Clin Exp Immunol       Date:  2017-09-15       Impact factor: 4.330

10.  Over-expression of TATA binding protein (TBP) and p53 and autoantibodies to these antigens are features of systemic sclerosis, systemic lupus erythematosus and overlap syndromes.

Authors:  R Chauhan; R Handa; T P Das; U Pati
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.